Growth Metrics

Conmed (CNMD) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.28%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 22.80%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -27.72%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -0.27%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 77.20%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -20.37%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.32%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn 48.97%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 48.97%
Dec 31, 2025 63.70%
Sep 30, 2025 36.23%
Jun 30, 2025 21.56%
Mar 31, 2025 136.57%
Dec 31, 2024 8.70%
Sep 30, 2024 44.65%
Jun 30, 2024 8.28%
Mar 31, 2024 12.09%
Dec 31, 2023 44.74%
Sep 30, 2023 8.56%
Jun 30, 2023 131.41%
Mar 31, 2023 -122.68%
Dec 31, 2022 -35.69%
Sep 30, 2022 -15.45%
Jun 30, 2022 -7.74%
Mar 31, 2022 24.94%
Dec 31, 2021 15.33%
Sep 30, 2021 427.57%
Jun 30, 2021 22.27%
Mar 31, 2021 -3.25%
Dec 31, 2020 -0.40%
Sep 30, 2020 48.51%
Jun 30, 2020 -48.51%
Mar 31, 2020 -58.69%
Dec 31, 2019 54.66%
Sep 30, 2019 13.00%
Jun 30, 2019 8.18%
Mar 31, 2019 25.68%
Dec 31, 2018 32.03%
Sep 30, 2018 -26.22%
Jun 30, 2018 37.92%
Mar 31, 2018 25.49%
Dec 31, 2017 -8.54%
Sep 30, 2017 -4.06%
Jun 30, 2017 58.09%
Mar 31, 2017 -0.64%
Dec 31, 2016 -25.22%
Sep 30, 2016 -4.35%
Jun 30, 2016 -1.25%
Mar 31, 2016 -154.15%
Dec 31, 2015 -32.66%
Sep 30, 2015 -24.98%
Jun 30, 2015 -31.70%
Mar 31, 2015 107.39%
Dec 31, 2014 1.66%
Sep 30, 2014 -30.22%
Jun 30, 2014 -39.68%
Mar 31, 2014 -7.84%
Dec 31, 2013 5.53%
Sep 30, 2013 71.52%